You're Sensitive to Indoor Chemicals. Your Genes Explain Why.

GSTM1 is one of your body’s main cleanup crew enzymes. Its job is to grab environmental toxins, pesticides, and VOCs that have been partially broken down by your phase I system, attach glutathione to them, and make them water-soluble so your kidneys can flush them out. It’s working right now, protecting your cells from oxidative damage and chemical accumulation.

Here’s the problem: roughly 50% of the population has a GSTM1 null genotype, meaning the gene is completely deleted. If you inherited two copies of the deletion (homozygous null), your body is missing this enzyme entirely. You have zero GSTM1 activity, which means your capacity to clear VOCs and environmental toxins drops by roughly 50% compared to someone with a functional copy. This single variant change means chemicals that should move through your bloodstream and out of your body instead linger and accumulate in fatty tissues.

When GSTM1 is deleted, VOCs from fresh paint, new furniture, or office renovations stay in your system longer. Your detox burden increases with every exposure. Over months and years, this chronic accumulation drives inflammation, mitochondrial stress, and the sensation that you’re becoming increasingly sensitive to smells that didn’t bother you before. It’s not that you’re becoming more sensitive. It’s that your body’s capacity to clear these chemicals is maxed out.

GSTP1 is a specialized phase II enzyme that handles a different class of toxins than GSTM1. While GSTM1 focuses on certain pesticides and aromatics, GSTP1 specializes in clearing the byproducts of oxidative stress that occur when your body is exposed to VOCs and environmental pollutants. It also neutralizes electrophilic compounds, which are highly reactive molecules that can damage cell membranes and DNA.

The Ile105Val variant (rs1695) occurs in roughly 35-40% of people. If you carry one or two copies of the Val allele, your GSTP1 enzyme works less efficiently. You have reduced capacity to neutralize the oxidative stress byproducts created during VOC exposure. This is especially problematic because it compounds the damage caused by slow detoxification. When VOCs linger in your body, they generate reactive oxygen species. If GSTP1 is slow, those damaging byproducts aren’t cleared quickly enough, leading to cell damage in the lungs, sinuses, and brain.

You experience this as persistent inflammation after chemical exposure. Your sinuses stay inflamed longer. Brain fog lingers for days after being in a newly carpeted office. Your eyes and throat remain irritated even after you’ve left the chemical source. The chemical is gone, but the oxidative damage is still being processed.

CYP1A2 is a phase I enzyme, which means its job is to begin the breakdown of VOCs and environmental chemicals. It’s the first responder. Phase I enzymes use oxidation to make toxins more reactive so they can then be handed off to phase II enzymes (like GSTM1 and GSTP1) for the final cleanup step. CYP1A2 specifically handles aromatic compounds and certain solvents you encounter indoors.

CYP1A2 variants are less common than GSTM1 or GSTP1 mutations, but when they occur, they significantly impact VOC handling. If you carry the Ile462Val variant, your CYP1A2 may have altered activity. The consequence is that VOCs that should be broken down into a form your phase II system can handle instead accumulate or break down incompletely, creating volatile intermediate metabolites. These intermediates can be more irritating than the original VOC, which is why you might feel worse during the detox process itself.

You experience this as a paradoxical reaction: you feel sicker when you’re trying to detoxify. A friend uses binders or activated charcoal and feels relief. You use the same protocol and feel worse. Or you move to a cleaner environment and your symptoms briefly intensify before improving. This is your phase I system working without adequate phase II backup.

MTHFR is not just a detoxification gene; it’s a master regulator of methylation, the biochemical process that powers your entire detox system. MTHFR converts dietary folate into the active form that your body uses to make S-adenosylmethionine (SAM), which fuels methylation reactions throughout your body. One of those critical reactions is the synthesis of glutathione, the master antioxidant and primary detox molecule in every cell.

The C677T variant occurs in roughly 40% of people with European ancestry. If you’re homozygous (TT), your MTHFR enzyme is roughly 35% less efficient. You produce less active folate and therefore less glutathione, which means your entire detox system is operating with a depleted fuel tank. You can have functional GSTM1, GSTP1, and CYP1A2 enzymes, but without enough glutathione, they can’t do their job effectively. It’s like having a perfectly good water pump with an empty reservoir.

You experience this as compounding sensitivity over time. Your tolerance for VOCs gets worse, not better, as you age. A low-glutathione state makes you more reactive to everything: smells, chemicals, foods, stress. Your recovery time from chemical exposure extends. You feel foggy and fatigued, not just during exposure, but persistently, because your cells are under constant oxidative stress.

SOD2 is the antioxidant enzyme that works inside your mitochondria, the power plants of your cells. When VOCs accumulate and your detox system is slow, the burden creates excessive free radicals (reactive oxygen species) that directly attack mitochondrial DNA. SOD2’s job is to convert those dangerous superoxide radicals into hydrogen peroxide, which is then cleaned up by other enzymes. If SOD2 is working well, your mitochondria stay protected. If it’s not, mitochondrial damage accelerates.

The Val16Ala variant (rs4880) is carried by roughly 40% of people with European ancestry. If you’re homozygous for the Ala allele (or have a Val/Ala mix), your SOD2 enzyme has reduced efficiency or cellular localization. Oxidative stress from VOC exposure accumulates faster in your mitochondria, causing cellular energy production to decline and fatigue to intensify. This is why some people with VOC sensitivity don’t just experience respiratory irritation; they experience profound fatigue, post-exertional malaise, and brain fog that persists long after chemical exposure ends.

You experience this as disproportionate exhaustion after chemical exposure. Your coworkers visit the newly renovated office and go about their day. You leave after two hours and need to rest for the next three days to recover. The chemical exposure itself isn’t that intense, but the mitochondrial burden makes recovery time prolonged. Your energy never quite stabilizes.

NQO1 is a phase II enzyme that specializes in detoxifying quinones, benzene metabolites, and other specific VOCs common in indoor environments. It’s activated by compounds like sulforaphane and quercetin. NQO1 works at the intersection of phase I and phase II, helping to neutralize intermediate metabolites that would otherwise cause oxidative damage. It’s especially important in indoor VOC exposure because office air, new construction materials, and office equipment emit quinone-based compounds.

The Pro187Ser variant (rs1800566) eliminates NQO1 activity entirely if you have two copies (null genotype). This occurs in roughly 4-20% of people depending on ancestry. A null NQO1 genotype means you have essentially zero capacity to handle quinones and certain benzene byproducts, making you specifically vulnerable to the VOC mixture in typical office and commercial buildings. Even if your GSTM1 and GSTP1 are functional, losing NQO1 creates a blind spot in your detox arsenal.

You experience this as particular sensitivity to specific indoor environments: offices with new carpet (benzene and quinones), newly painted rooms, or areas near laser printers and electrical equipment. Your sensitivity isn’t generalized. It’s targeted to sources high in quinones. You might be fine in a naturally-lit home with old wood furniture, but react intensely to a modern office with synthetic materials.